| The stroke preclinical assessment network: rationale, design, feasibility, and stage 1 results PD Lyden, F Bosetti, MA Diniz, A Rogatko, JI Koenig, J Lamb, ... Stroke 53 (5), 1802-1812, 2022 | 28 | 2022 |
| Embracing heterogeneity in the multicenter Stroke Preclinical Assessment Network (SPAN) trial A Morais, JJ Locascio, LH Sansing, J Lamb, K Nagarkatti, T Imai, ... Stroke 54 (2), 620-631, 2023 | 14 | 2023 |
| Accelerated and quantitative three‐dimensional molecular MRI using a generative adversarial network J Weigand‐Whittier, M Sedykh, K Herz, J Coll‐Font, AN Foster, ... Magnetic Resonance in Medicine 89 (5), 1901-1914, 2023 | 11 | 2023 |
| Tailored chemical reactivity probes for systemic imaging of aldehydes in fibroproliferative diseases H Ma, IY Zhou, YI Chen, NJ Rotile, I Ay, EA Akam, H Wang, RS Knipe, ... Journal of the American Chemical Society 145 (38), 20825-20836, 2023 | 3 | 2023 |
| Partial volume correction of PET image data using geometric transfer matrices based on uniform B-splines JB Mandeville, N Efthimiou, J Weigand-Whittier, E Hardy, GM Knudsen, ... Physics in Medicine & Biology 69 (5), 055020, 2024 | 1 | 2024 |
| Amphetamine pretreatment blunts dopamine-induced D2/D3-receptor occupancy by an arrestin-mediated mechanism: A PET study in internalization compromised mice JB Mandeville, J Weigand-Whittier, HY Wey, YCI Chen Neuroimage 283, 120416, 2023 | 1 | 2023 |
| Optimization of an Allysine-Targeted PET Probe for Quantifying Fibrogenesis in a Mouse Model of Pulmonary Fibrosis S Shuvaev, RS Knipe, M Drummond, NJ Rotile, I Ay, JP Weigand-Whittier, ... Molecular Imaging and Biology 25 (5), 944-953, 2023 | 1 | 2023 |
| Exploring The Therapeutic Potential Of Empagliflozin And Oral Ketone Ester In HFpEF: A Study On Cardiac Function, Structure, And Metabolism SR Yurista, W Jiang, C Shi, RA Eder, F Liu, J Weigand-Whittier, ... Journal of Cardiac Failure 30 (1), 279, 2024 | | 2024 |
| Unveiling the Therapeutic Potential of SGLT2 inhibitors and Oral Ketone Ester in Heart Failure with Preserved Ejection Fraction: A Comprehensive Exploration of Cardiac Function … SR Yurista, DG Bedoya, RA Eder, C Shi, W Jiang, F Liu, ... American Heart Journal 267, 118, 2024 | | 2024 |
| Exploring the Therapeutic Potential of SGLT2 Inhibitors and Oral Ketone Ester in HFpEF: A Comprehensive Exploration of Cardiac Function, Structure, and Metabolism in a Rat Model S Yurista, D Guarin Bedoya, R Eder, S Chen, W Jiang, A Welsh, F Liu, ... Circulation 148 (Suppl_1), A13962-A13962, 2023 | | 2023 |
| Detection of Pulmonary Fibrosis with a Collagen-Mimetic Peptide IM Borgula, S Shuvaev, E Abston, NJ Rotile, J Weigand-Whittier, IY Zhou, ... ACS sensors 8 (11), 4008-4013, 2023 | | 2023 |
| Collagen type I PET/MRI for evaluation of treatment response in pancreatic cancer; results of pre-clinical and first in-human translational studies S Esfahani, H Ma, S Krishna, S Shuvaev, B Ataeinia, N Rotile, JW Whittier, ... Journal of Nuclear Medicine 64 (supplement 1), P625-P625, 2023 | | 2023 |
| THE EFFECTS OF EMPAGLIFLOZIN AND ORAL KETONE ESTER ON CARDIAC FUNCTION, STRUCTURE, AND METABOLISM IN HEART FAILURE WITH PRESERVED EJECTION FRACTION S Yurista, W Jiang, R Eder, S Chen, F Liu, J Weigand-Whittier, ... Journal of the American College of Cardiology 81 (8_Supplement), 330-330, 2023 | | 2023 |
| Simultaneous PET and molecular MR imaging of cardiopulmonary fibrosis in a mouse model of left ventricular dysfunction BF Moon, IY Zhou, Y Ning, YI Chen, M Le Fur, S Shuvaev, EA Akam, H Ma, ... bioRxiv, 2023.12. 15.571959, 2023 | | 2023 |
| Tracking the Migration of Injectable Microdevices in the Rodent Brain Using a 9.4 T Magnetic Resonance Imaging Scanner A Khalifa, J Weigand-Whittier, CT Farrar, S Cash Frontiers in Neuroscience 15, 738589, 2021 | | 2021 |
Christopher T NguyenDirector, Cardiovascular Innovation Research Center, Cleveland ClinicVerified email at ccf.org
